Global Long Acting Injectable Anti-Psychotic Market: Size, Trends & Forecasts 2017-2021 Featuring Johnson & Johnson, Eli Lily and Company, Alkermes and Lundbeck - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Long Acting Injectable Anti-psychotic Market: Size, Trends & Forecasts (2017-2021)" report to their offering.

Global Long Acting Injectable Anti-psychotic Market: Size, Trends & Forecasts (2017-2021), provides analysis of the global injectable anti-psychotic market, with detailed analysis of market size and growth, and segmentation of the industry.

The report also includes a detailed regional analysis of the long acting injectable anti-psychotic market in the region of the US. Under competitive landscape, different products in the long acting injectable anti-psychotic market have been compared on the basis of different parameters such as dosing frequency, patent expiry, injection sites, label, storage, needles and available strengths. Also, a financial comparison of long acting injectable market players in the US has been done.

Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global long acting injectable anti-psychotic market has also been forecasted for the years 2017-2021, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

Johnson & Johnson, Eli Lily and Company, Alkermes Public Limited Company and Lundbeck are some of the key players operating in the global long acting injectable anti-psychotic market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided.

Market Dynamics

Growth Drivers

  • Increasing Cases of Schizophrenia
  • Rising Bipolar Disorder Patients
  • Non Adherence to Oral Anti-psychotic

Challenges

  • Side Effects of Anti-psychotic
  • Patent Expirations of Certain Brands

Market Trends

  • Aging Demography
  • Grant of Approval to Trevicta in European Commission
  • Third Party Proprietary Technologies
  • Expanding Labeling of Abilify Maintena

Key Topics Covered:

1. Executive Summary

2. Introduction

3. Global Market Analysis

4. Regional Analysis

5. Market Dynamics

6. Competitive Landscape

7. Company Profiling

For more information about this report visit http://www.researchandmarkets.com/research/shjsq3/global_long

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infusions and Injectables

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infusions and Injectables